Prospective , Multicentric, Randomized Phase II Study, Evaluating the Role of Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue After Conventional Chemotherapy for Primary Central Nervous System in Young Patients (< 60 y)
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
2-years progression-free survival in each arm
2 years after inclusion
Yes
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
CRH 07/422/H
NCT00863460
October 2008
March 2015
Name | Location |
---|